Picton Mahoney Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
36
-558
| -94% | -$15.5K | ﹤0.01% | 901 |
|
|
2025
Q1 | $19K | Buy |
594
+558
| +1,550% | +$17.8K | ﹤0.01% | 561 |
|
|
2024
Q4 | $1K | Hold |
36
| – | – | ﹤0.01% | 777 |
|
|
2024
Q3 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 771 |
|
|
2017
Q1 | – | Sell |
-6,400
| Closed | -$161K | – | 211 |
|
|
2016
Q4 | $161K | Sell |
6,400
-8,600
| -57% | -$216K | 0.01% | 166 |
|
|
2016
Q3 | $371K | Buy |
15,000
+200
| +1% | +$4.95K | 0.02% | 187 |
|
|
2016
Q2 | $301K | Buy |
+14,800
| New | +$301K | 0.02% | 199 |
|
|
2016
Q1 | – | Sell |
-50,500
| Closed | -$679K | – | 338 |
|
|
2015
Q4 | $679K | Sell |
50,500
-24,800
| -33% | -$333K | 0.04% | 174 |
|
|
2015
Q3 | $1.06M | Buy |
+75,300
| New | +$1.06M | 0.06% | 153 |
|